Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on N Halosuccinimide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114292153A reveals a mild catalytic halogenation method using tertiary amines. This breakthrough offers cost reduction in pharmaceutical intermediate manufacturing with high selectivity.
Patent CN108147989B reveals a one-pot synthesis of beta-amino ketones using allyl alcohols, offering high yields and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN112573978A reveals a high-yield sulfoxide-catalyzed halogenation method offering significant cost reduction and safety improvements for pharmaceutical intermediate manufacturing.
Patent CN102558004A reveals a mild, high-yield synthesis route for S-(4-tolyl)benzenesulfonate, offering significant cost reduction and supply chain stability for fine chemical manufacturing.